T1	Participants 44 64	children with autism
T2	Participants 144 177	children (5-12 years) with autism
T3	Participants 414 469	55 children given risperidone (n=27) or placebo (n=28);
T4	Participants 532 583	Risperidone [mean dose ( +/- SD): 1.37 mg/day (0.7)
